<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Penn_ProjectOverview"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Penn/ProjectOverview">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Penn/ProjectOverview&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Penn/ProjectOverview&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Penn/ProjectOverview&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Penn/ProjectOverview" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Penn/ProjectOverview</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><P><TITLE>Penn 2012 iGEM Wiki</TITLE></P></DIV><UL class="nav"><LI class="dropdown"><A href="/Team:Penn/ProjectOverview" style="font-size:13px;">Our Project</A></LI><LI><A href="/Team:Penn/ProjectOverview">Motivation</A></LI><LI><A href="/Team:Penn/ProjectResults">Our Therapeutic</A></LI><LI><A href="/Team:Penn/Achievements">Achievements</A></LI></UL><LI class="dropdown"><A href="/Team:Penn/LightActivatedOverview" style="font-size:13px;">Light Activation</A></LI><LI><A href="/Team:Penn/LightActivatedOverview">Overview</A></LI><LI><A href="/Team:Penn/BLSensor">YF1/FixJ BL Sensor</A></LI><LI><A href="/Team:Penn/LightActivatedLysis">Light Activated Cell Lysis</A></LI><LI class="dropdown"><A href="/Team:Penn/SurfaceDisplayOverview" style="font-size:13px;">Surface Display</A></LI><LI><A href="/Team:Penn/SurfaceDisplayOverview">Overview</A></LI><LI><A href="/Team:Penn/SurfaceDisplay">INPNC Surface Display</A></LI><LI><A href="/Team:Penn/Targeting">HER2 Targeting </A></LI><LI><A href="/Team:Penn/SurfaceDisplayBBa">BBa Surface Display Platform</A></LI><LI class="dropdown"><A href="#" style="font-size:13px;">Wet Lab</A></LI><LI><A href="/Team:Penn/Notebook">Notebook</A></LI><LI><A href="/Team:Penn/Safety">Safety</A></LI><LI><A href="/Team:Penn/Protocols">Protocols</A></LI><LI><A href="/Team:Penn/Parts">Parts</A></LI><LI class="dropdown"><A href="/Team:Penn/HumanPracticesOverview" style="font-size:13px;">Human Practices</A></LI><LI><A href="/Team:Penn/HumanPracticesOverview">Overview</A></LI><LI><A href="/Team:Penn/Barriers">Bacterial Therapeutics</A></LI><LI><A href="/Team:Penn/Outreach">Outreach</A></LI><LI><A href="/Team:Penn/Perceptions">Public Perception</A></LI><LI><A href="/Team:Penn/Nissle">E. Coli Nissle 1917</A></LI><LI><A href="/Team:Penn/VerifiGEM">VerifiGEM</A></LI><LI class="dropdown"><A href="/Team:Penn/Team" style="font-size:13px;">About Us</A></LI><LI><A href="/Team:Penn/Team">Team</A></LI><LI><A href="/Team:Penn/Sponsors">Sponsors</A></LI><DIV class="bigbox"><B><DIV class="name" align="center">Motivation</DIV></B><P style="color:black;text-indent:30px;">

Medicine is a challenge of optimization.  When treating a disease, doctors and physicians want to maximize the on-target, beneficial effects of a therapy while minimizing the off-target or side effects.   We identified two main optimization parameters for current medical therapies: <B>specificity</B> and <B>dosage control.</B></P><DIV class="name" align="center">Specificity</DIV><P style="color:black;text-indent:30px;">


Current therapies generally rely on either spatial targeting (within a physical area) or cellular targeting (to a specific antigen or biomarker).  However, these methods still have high nonspecific effects on healthy tissue.  For example, cancer radiation therapy can spatially target and kills tumor cells, but it effects all cells in the target area.  Effectiveness of radiation therapy is therefore limited to when the cancer is highly localized and when the tumor area is well defined.  Chemotherapy and monoclonal antibody therapies are able to target by cell type, but they target even healthy cells throughout the body that express the antigen or biomarker.  This is why patients undergoing chemotherapy exhibit horrible side effects: the treatment targets and kills all rapidly dividing cells, including healthy hair, skin, and organ cells.
</P><DIV align="center"><TABLE width="860" cellspacing="20" style="background-color:#d7dce1;"><TBODY><TR valign="top"><TD><P style="text-align:justify;"><B>Spatial Targeting:</B> Surgeons excise a tumor manually, without regard for cellular heterogeneity within and around the tumor area.</P></TD><TD><P style="text-align:justify;"><B>Cellular Targeting:</B> Monoclonal antibodies identify antigens on certain cells or viruses. Monoclonal antibodies are often coupled with therapeutic agents. However, if the antigen is present in healthy tissue outside the diseased area, it will be targeted as well.</P></TD></TR></TBODY></TABLE></DIV><B><DIV class="name" align="center">Dosage Control</DIV></B><P style="color:black;text-indent:30px;">Precise dosage control is difficult in current medical therapies.  Relying on passive diffusion makes dose precision hard to determine – of the dose injected into the body, how much of it actually reaches its target?  Innovation in pharmacology therefore focuses on increasing the therapeutic window - the range of drug dose that is considered both effective and safe – so that doses may be increased if necessary.  Modern chemical therapise then focuses on maximizing the amount of time a drug dose falls in the therapeutic window, while being careful to not overlap into the range of toxicity.  The riskiest drug therapies therefore becomes a race – will the treatment kill the disease before the treatment kills the patient?</P><DIV align="center"><TABLE width="860" cellspacing="20" style="background-color:#d7dce1;"><TBODY><TR valign="top"><TD><P style="text-align:justify;"><B>Therapeutic Window:</B> Modern drug therapy focuses on maintaining an effective concentration of a drug within the therapeutic window by timing of doses.  It is very difficult to maintain a constant dose, however, which leads to the risk of overdosing. </P></TD><TD><P style="text-align:justify;"><B>Toxic and Lethal Effects:</B> If drug doses become too high, toxic or even lethal effects may occur.  In the riskiest drug therapies such as chemotherapy, there is very little space between the Effective Dose, Toxic Dose, and Lethal Dose curves, making dose control incredibly important. </P></TD></TR></TBODY></TABLE></DIV><B><DIV class="name" align="center">Our Question:</DIV></B><B><DIV class="name" align="center" style="font-size:20px;"><A href="https://2012.igem.org/Team:Penn/ProjectResults">How Can Synthetic Biology Improve Medicine?</A></DIV></B><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Penn/ProjectOverview">http://2012.igem.org/Team:Penn/ProjectOverview</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Penn/ProjectOverview" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Penn/ProjectOverview" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Penn/ProjectOverview&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Penn/ProjectOverview&amp;oldid=292186" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>